Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 178410, 8 pages
http://dx.doi.org/10.1155/2014/178410
Research Article

Metadherin, p50, and p65 Expression in Epithelial Ovarian Neoplasms: An Immunohistochemical Study

1Department of Anatomy, School of Medicine, University of Patras, 26500 Patras, Greece
2Department of Medical Oncology, Imperial College, London W6 8RF, UK
3Department of Pathology, “Agios Andreas” Hospital, 26335 Patras, Greece
4Department of Pathology, Elena Venizelou Hospital, 11521 Athens, Greece

Received 23 February 2014; Revised 8 May 2014; Accepted 10 May 2014; Published 22 May 2014

Academic Editor: Alfredo Conti

Copyright © 2014 Ioanna Giopanou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. EUCAN Cancer Factsheets: Ovary, 2013, http://eu-cancer.iarc.fr/EUCAN/CancerOne.aspx?Cancer=27&Gender=2.
  2. M. Karin, “Nuclear factor-κB in cancer development and progression,” Nature, vol. 441, no. 7092, pp. 431–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C. M. Annunziata, H. T. Stavnes, L. Kleinberg et al., “Nuclear factor κB transcription factors are coexpressed and convey a poor outcome in ovarian cancer,” Cancer, vol. 116, no. 13, pp. 3276–3284, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R.-X. Guo, Y.-H. Qiao, Y. Zhou, L.-X. Li, H.-R. Shi, and K.-S. Chen, “Increased staining for phosphorylated AKT and nuclear factor-κB p65 and their relationship with prognosis in epithelial ovarian cancer,” Pathology International, vol. 58, no. 12, pp. 749–756, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Hernandez, S. C. Hsu, B. Davidson, M. J. Birrer, E. C. Kohn, and C. M. Annunziata, “Activation of NF-κB signaling by inhibitor of NF-κB kinase β increases aggressiveness of ovarian cancer,” Cancer Research, vol. 70, no. 10, pp. 4005–4014, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. B. Alvero, “Recent insights into the role of NF-κB in ovarian carcinogenesis,” Genome Medicine, vol. 2, no. 8, article 56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. Z.-Z. Su, D.-C. Kang, Y. Chen et al., “Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH,” Oncogene, vol. 21, no. 22, pp. 3592–3602, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Y. Kim, E. A. Welsh, U. Oguz, B. Fang, Y. Bai, and F. Kinose, “Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 30, pp. 12414–12419, 2013. View at Google Scholar
  9. X. Kong, M. S. Moran, Y. Zhao, and Q. Yang, “Inhibition of metadherin sensitizes breast cancer cells to AZD6244,” Cancer Biology and Therapy, vol. 13, no. 1, pp. 43–49, 2012. View at Google Scholar
  10. X. Ge, X. Lv, L. Feng et al., “Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma,” PLoS ONE, vol. 7, Article ID e39449, p. 6, 2012. View at Google Scholar
  11. S. Ahn, J. Hyeon, and C. K. Park, “Metadherin is a prognostic predictor of hepatocellular carcinoma after curative hepatectomy,” Gut and Liver, vol. 7, no. 2, pp. 206–212, 2013. View at Google Scholar
  12. C. Yu, Y. Liu, H. Tan, G. Li, Z. Su, and S. Ren, “Metadherin regulates metastasis of squamous cell carcinoma of the head and neck via AKT signalling pathway-mediated epithelial-mesenchymal transition,” Cancer Letters, vol. 343, no. 2, pp. 258–267, 2014. View at Google Scholar
  13. C. Wu, B. Jin, L. Chen et al., “MiR-30d induces apoptosis and is regulated by the Akt/FOXO pathway in renal cell carcinoma,” Cell Signal, vol. 25, no. 5, pp. 1212–1221, 2013. View at Google Scholar
  14. S.-G. Lee, H.-Y. Jeon, Z.-Z. Su et al., “Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma,” Oncogene, vol. 28, no. 26, pp. 2476–2484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Kikuno, H. Shiina, S. Urakami et al., “Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity,” Oncogene, vol. 26, no. 55, pp. 7647–7655, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Liu, J. Wu, Z. Ying et al., “Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion,” Cancer Research, vol. 70, no. 9, pp. 3750–3759, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Song, C. Li, R. Li, and J. Geng, “Prognostic significance of AEG-1 expression in colorectal carcinoma,” International Journal of Colorectal Disease, vol. 25, no. 10, pp. 1201–1209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J.-B. Xu, H. Wu, Y.-L. He et al., “Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer,” Medical Oncology, vol. 28, no. 2, pp. 455–462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. B. K. Yoo, L. Emdad, S.-G. Lee et al., “Astrocyte elevated gene-1 (AEG-1): a multifunctional regulator of normal and abnormal physiology,” Pharmacology and Therapeutics, vol. 130, no. 1, pp. 1–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Emdad, D. Sarkar, Z.-Z. Su et al., “Activation of the nuclear factor κB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis,” Cancer Research, vol. 66, no. 3, pp. 1509–1516, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Sarkar, S. P. Eun, L. Emdad, S.-G. Lee, Z.-Z. Su, and P. B. Fisher, “Molecular basis of nuclear factor-κB activation by astrocyte elevated gene-1,” Cancer Research, vol. 68, no. 5, pp. 1478–1484, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Li, J. Liu, R. Lu et al., “AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers,” International Journal of Gynecological Cancer, vol. 21, no. 4, pp. 602–608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Meng, C. Luo, L. Ma, Y. Hu, and G. Lou, “Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma,” International Journal of Gynecological Pathology, vol. 30, no. 2, pp. 145–150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Li, Y. Li, X. Wang et al., “Elevated expression of astrocyte elevated gene-1 (AEG-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages III-IV serous ovarian carcinoma,” Histopathology, vol. 60, no. 6, pp. 953–963, 2012. View at Google Scholar
  25. X. Meng, D. Zhu, S. Yang et al., “Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein,” Journal of Biological Chemistry, vol. 287, no. 7, pp. 4485–4491, 2012. View at Google Scholar
  26. J. S. Ross, B. V. S. Kallakury, C. E. Sheehan et al., “Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence,” Clinical Cancer Research, vol. 10, no. 7, pp. 2466–2472, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Weichert, M. Boehm, V. Gekeler et al., “High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis,” British Journal of Cancer, vol. 97, no. 4, pp. 523–530, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Nair, M. Venkatraman, T. T. Maliekal, B. Nair, and D. Karunagaran, “NF-κB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix,” Oncogene, vol. 22, no. 1, pp. 50–58, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Barkett and T. D. Gilmore, “Control of apoptosis by Rel/NF-κB transcription factors,” Oncogene, vol. 18, no. 49, pp. 6910–6924, 1999. View at Google Scholar · View at Scopus
  30. S. Darb-Esfahani, B. V. Sinn, W. Weichert et al., “Expression of classical NF-κB pathway effectors in human ovarian carcinoma,” Histopathology, vol. 56, no. 6, pp. 727–739, 2010. View at Publisher · View at Google Scholar · View at Scopus